NTI 5.17% 6.1¢ neurotech international limited

Ann: NTI Receives HREC Approval for Rett Syndrome Clinical Trial, page-2

  1. 199 Posts.
    lightbulb Created with Sketch. 62
    Any update on the phase II/III trials that might turn in to commercialisation? Cause that might move the SP from its slumber on the bottom of the charts.
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
6.1¢
Change
0.003(5.17%)
Mkt cap ! $62.06M
Open High Low Value Volume
5.9¢ 6.3¢ 5.8¢ $45.38K 746.0K

Buyers (Bids)

No. Vol. Price($)
1 40246 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.1¢ 13319 1
View Market Depth
Last trade - 15.59pm 20/06/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.